Matthew Hawryluk's Insider Trades & SAST Disclosures
Matthew Hawryluk's most recent trade in Gritstone Bio Inc was a trade of 180,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 15, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Matthew Hawryluk.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Gritstone Bio Inc | Matthew J. Hawryluk | EVP, CHIEF BUSINESS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 180,000 | 180,000 | - | - | Stock Option (Right to Buy) | |
| Gritstone Bio Inc | Matthew J. Hawryluk | EVP, CHIEF BUSINESS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 19,149 | 323,190 (0%) | 0% | 0 | Common Stock | |
| Gritstone Bio Inc | Matthew J. Hawryluk | EVP, CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 0.75 per share. | 15 May 2024 | 9,259 | 313,931 (0%) | 0% | 0.7 | 6,929 | Common Stock |
| Predictive Oncology Inc | Matthew J. Hawryluk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2024 | 2,368 | 9,488 (0%) | 0% | 0 | Common Stock | |
| Gritstone Bio Inc | J. Matthew Hawryluk | EVP, CHIEF BUSINESS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 180,000 | 180,000 | - | - | Stock Option (Right to Buy) | |
| Gritstone Bio Inc | Matthew J. Hawryluk | EVP, CHIEF BUSINESS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 35,000 | 286,880 (0%) | 0% | 0 | Common Stock | |
| Predictive Oncology Inc | Matthew Hawryluk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2023 | 2,675 | 5,260 (0%) | 0% | 0 | Common Stock | |
| Predictive Oncology Inc | Matthew Hawryluk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 18,360 | 51,692 (1%) | 0% | 0 | Common Stock | |
| Gritstone Bio Inc | Matthew Hawryluk | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 191,771 | 248,311 (0%) | 0% | 0 | Common Stock | |
| Predictive Oncology Inc | Matthew Hawryluk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 19,570 | 33,332 (0%) | 0% | 0 | Common Stock | |
| Predictive Oncology Inc | Matthew Hawryluk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2022 | 13,762 | 13,762 (0%) | 0% | 0 | Common Stock | |
| Gritstone Bio Inc | Matthew Hawryluk | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 129,675 | 129,675 | - | - | Stock Option (Right to Buy) | |
| Gritstone Bio Inc | Matthew Hawryluk | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 21,612 | 53,351 (0%) | 0% | 0 | Common Stock | |
| Gritstone Bio Inc | Matthew Hawryluk | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2021 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Gritstone Bio Inc | Matthew Hawryluk | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2021 | 19,600 | 24,198 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges